share_log

西藏药业2024年半年度报告摘要

Summary of Tibet Rhodiola Pharmaceutical Holding's H1 2024 report.

SZSI ·  Aug 14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more